Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review

PHARMACOGENOMICS & PERSONALIZED MEDICINE · Published 2026-07-01 · DOI 10.2147/pgpm.s591506

Free full text

Authors (2)

Panfeng Xu, Shan Lu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Xu, P., Lu, S. (2026). Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review. PHARMACOGENOMICS & PERSONALIZED MEDICINE. https://doi.org/10.2147/pgpm.s591506

Related articles

• The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2025 · Same journal
• Association Between ABCB1 Gene Polymorphism with Hyperglycemia and MACE in Patients Undergoing Clopidogrel Treatment After PCI · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2025 · Same journal
• Whole Exome Sequencing Reveals Novel Genetic Variants Associated with Atrial Septal Defect in a Tibetan Patient Cohort · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2025 · Same journal
• Naoxintong Is Involved in the Coagulation Regulation of Warfarin Through the MAPK Pathway · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2025 · Same journal
• Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2024 · Same journal
• Preliminary Study on Clinical Characteristics and Pathogenesis of IQSEC2 Mutations Patients · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2024 · Same journal
• Molecular Epidemiology of Thalassemia in University Town, Chongqing: Spectrum of Pathogenic Variants and Implications for Carrier Screening · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2026 · Same journal
• Novel SLC16A2 Frameshift Mutation as a Cause of Allan-Herndon-Dudley Syndrome and its Implications for Carrier Screening · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2025 · Same journal
• Cuproptosis-Related lncRNA Predict Prognosis and Immune Response of LUAD · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2024 · Same journal
• Genetic Diversity Landscape in African Population: A Review of Implications for Personalized and Precision Medicine · PHARMACOGENOMICS & PERSONALIZED MEDICINE · 2024 · Same journal